Anemia Therapeutics Flashcards

1
Q

IDA treatment Aim

A

Replenish iron stores but also equally important is to identify what caused iron deficiency in the first place

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

IDA: Treatment: Food

A

meat iron more absorbable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IDA: Iron Supplement: What sort of tablets?

A
  • Enteric coated products and slow-release products are not reccomended. It would cause release too far distally.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

IDA: Iron Supplement: How to Take?

A
  • Best taken on an empty stomach as food interferes with absorption (see if you can tolerate it first)
  • But iron causes constipation, N/V/D, stomach upset, other intolerances. Just accept the fact they wont absorb it as well
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

IDA: Iron Supplement: Dose?

A
  • Dose: 100-200 mg elemental iron per day, usually in 1-3 divided doses, for 3-6 months after anemia is resolved to build up iron stores. Due to poor tolerability, start lower and titrate up.
  • Evidence that low doses are just as effective in elderly patients.
  • Not dosing everyday (every other day) is just as good as dosing it everyday
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

IDA: Treatment Table for doses

A

Differs between 3 products. Ferrous gluconate (35mg), ferrous sulfate (60mg), Ferrous fumarate (100mg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IDA: Treatment Table for doses: Iron polysaccharide

A

better absorbed and better marketed. Not a lot of good evidence…. but anadoctal evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

IDA: Treatment Table for doses: Heme Iron Polypeptide

A

Better absorbed, better tolerated, and less likely to interact with food. Have some clinical evidence for use. So only need 1-3 tabs day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

IDA: Treatment Table for doses:Iron bisglycinate

A

Better absorbed, better tolerated, and less likely to interact with food. Have some clinical evidence for use. So only need 1-3 tabs day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IDA Treatment Guide

A

1st line is one of the top 3 traditional iron salts first. If patients cant tolerate iron salts, try the other 3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Strategies to improve tolerability

A
  • Increasing dosing interval
  • Switching formulations with lower amounts of elemental iron
  • Start at lower dose, then titrate up
  • Switching from tablet to liquid, easier titration
  • Dietary modifications (take with food or milk)- *sometimes better to take with food rather than stopping it !!!! *
  • Can switch to IV iron (usually saved as last resort)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drug Interactions with Oral Iron

A

Non heme iron required an acidic environment to be absorbed. Anything that decreases acidity might interact with this process.
Cholestyramine- bile acid diarrhea for gallbladder-less patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How long do you separate iron from object drugs affected by iron?

A

2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IDA: Treatment: Oral Iron

A
  • Ferrous sulfate 75 mg/mL oral liquid (ODB)
  • Ferrous gluconate 300 mg tabs (ODB)
  • Ferrous fumarate 300 mg caps, 60 mg/mL liquid (ODB)
  • Iron polysaccharide complex caps, tabs, liquid, powder (not covered by ODB)
  • Proferrin® tabs (heme iron) (not covered by ODB)
  • Iron bisglycinate tabs (not covered on ODB)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Parenteral Iron is reserved for patients who?

A
  • Are unable to* tolerate* or *absorb *oral iron
  • Have extensive chronic blood loss or extreme deficit in iron stores who cannot be maintained with oral iron alone
  • Need rapid correction of anemia
    Also used in some patients with severe chronic kidney disease (esp. if on hemodialysis), some patients with cancer = evidence that it is better compared to oral !!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Iron Deficiency Anemia: Treatment – Parenteral Iron

A

Iron dextran (Infufer®, Dexiron®)
IM – very painful, possible tissue staining
IV – hypersensitivity and anaphylactic reactions possible (test doses should be given)
[DISCONTINUED IN CANADA !!]

17
Q

Iron Deficiency Anemia: Treatment – Parenteral Iron

A

**Iron sucrose (Venofer®)
**IV only, less likely to cause hypersensitivity reactions
* Test dose not required, but consider if the patient has a history of multiple drug allergies
* Officially indicated for treatment of IDA in CKD patients only

18
Q

Iron Deficiency Anemia: Treatment – Parenteral Iron

Sodium ferric gluconate (Ferrlecit®)

A

Sodium ferric gluconate (Ferrlecit®)
* IV only, have caused hypersensitivity reactions in patients not undergoing hemodialysis
Test dose not required, but consider if the patient has a history of multiple drug allergies
Officially indicated for treatment of IDA in hemodialysis patients receiving supplemental EPO

19
Q

Iron Deficiency Anemia: Treatment – Parenteral Iron

Iron isomaltoside (Monoferric®)

A
  • IV only, less likely to cause hypersensitivity reactions. VERY LOW so test dose not required
  • Benefit is that a full dose up to 1500mg or 20 mg iron/kg (whatever lower) can be given in one IV infusion session, unlike other available products
    Officially indicated for any patient with IDA intolerant to oral therapy
20
Q

Notes about Parenteral Iron

A
  • All are efficacious
  • Oral iron absorption decreased while on IV; stop oral if on IV therapy
  • All products carry a risk for anaphylactoid reactions (bronchospasm, pruritus/rash, anaphylactic shock) and infusion reactions (hypotension – most common, flushing, palpitations, shortness of breath, fever, nausea)
  • Should never be infused too quickly
    – Transferrin binding sites can be overloaded, resulting in excess free iron in the bloodstream that can interfere with neutrophil function, perpetuate inflammatory reactions, and compromise active treatment of a coexisting infection
21
Q

Iron Deficiency Anemia: Treatment – Parenteral Iron: Test Question: Female 70 kg, desired Hgb 13 g/dL, current Hgb 10 g/dL

Whats the total dose iron (mg) needed?

A

Total dose of iron (mg) = [(13-10) x 70 x 2.2] + 600  1000 mg
Don’t give all at one visit (exception: iron isomaltoside) ; usually in divideddoses of no more than elemental iron per dose (protocols
vary), > 48 hours between doses
– In clinical practice, max cumulative dose usually 1000-1500mg per 14-day period course, but protocols vary widely.

22
Q

IV Iron infusion Pre-medication

A
  • Typically reserved for patients at highest risk (Hx of infusion reaction), (Asthma), ( >1 drug allergy)
  • If used, typically will include an IV steroid (e.g. methylprednisolone) +/- IV H2RA (e.g. ranitidine) OR IV H1RA (e.g. diphenhydramine)
  • Protocol is clinic-specific
  • Concern that s/e to premedication can mimic infusion reactions
23
Q

IDA: Adverse Effects of Treatment : Oral

A
  • Primarily GI (loss of appetite, nausea, vomiting, constipation, stools may appear darker in color)
  • Liquid iron may temporarily stain the teeth – dilute and take through a straw to avoid staining
24
Q

IDA: Adverse Effects of Treatment: IV

A
  • Immediate hypersensitivity reaction, anaphylaxis very rare
  • Serum sickness (lymphadenopathy, myalgia, arthralgia, fever, and headache) 4-48 hours after infusion
  • Hypotension/flushing associated with rapid injection
25
Monitoring for efficacy and safety: Oral iron therapy
Efficacy: Reticulocytosis within 5-7 days (not routinely monitored)- spike in reticulocytes will occur Monitor CBC/Ferritin every 1-2 months We want to see an Increase in 10 g/L of hemoglobin every 7–10 days --> If improved by less than 20 g/L over 3 weeks, investigate other causes of anemia Hgb should **reach normal** by *2 months* Ferritin should reach normal by 3-6 months Safety: Ongoing monitoring for GI intolerances -Usually occur within days-weeks of starting medication (usually starts right away, but pattern should be monitored for weeks). DONT say Monitor 3 months from now. !!!!!
26
Monitoring for efficacy and safety: Parenteral iron therapy | Efficacy and Safety
**Efficacy** Response time for anemia resolution with parenteral iron is generally similar to oral iron, but because IV iron circumvents absorption issues, Hgb rise is typically faster **Safety** Immediate hypersensitivity reaction monitoring (during and immediately after infusion); delayed hypersensitivity reaction **within 2 days after injection** Monitor monthly: ferritin, TSAT to assess for overload (ferritin>800 ng/mL; TSAT>50) Symptoms of iron overload, LFTs | general rule of thumb.
27
B12 Deficiency Anemia: What drug do we have to pay attention for?
Metformin. This medication causes decreased absorption. Check B12 levels once a year. Long term use will impact B12 levels. Use supplements often.
28
B12 Deficiency Anemia: Treatment Option 1: Parental IM Injection | ID and Dose?
Can give IM (Cyanocobalamin – synthetic form of B12) * 1000 µg IM daily for 1-2 weeks to saturate B12 stores, followed by 100-1000 µg per week until clinical manifestations resolve * Then monthly injections of 100-1000 µg until cause is resolved (potentially for whole life) * 1000 µg dose is often used by convention *** FOR PATIENTS WITHOUT ANEMIA**: (Lower dose, 1000 µg IM weekly until deficiency corrected, then once monthly thereafter)
29
B12 Deficiency Anemia: Treatment Option 2: Oral B12
**Lower dose Oral B12 + oral intrinsic factor** antibodies to intrinsic factor often prevent long-term success **Higher dose Oral B12 alone** can also be used due to an intrinsic factor independent absorption mechanism Large doses are required since the mean absorption rate in patients with pernicious anemia is 1.2%. 1000 - 2000 mcg/day. Can be given SL if patient prefers
30
B12 Deficiency Anemia: Treatment Option 3: Intranasal B12
**Intranasal B12 gel/spray (500 mcg/0.1 mL)** More bioavailable than the oral route 500 mcg in one nostril **once weekly** Do not administer within one hour before or after ingesting hot foods or beverages (increase nasal secretions and may cause the gel to be washed out of the nostril) Vitamin B12** levels should be checked one month** after 1 month; if levels decline, a higher dose may be required If used, suggest reserve for maintenance therapy after hematologic parameters have normalized
31
F &M : Vitamin B12 Deficiency Monitoring for Efficacy
Improved strength and well-being in a few days Bone marrow becomes normoblastic within 24 hours Reticulocytosis begins within 3-5 days Check CBC and serum Vit B12 levels in 1-2 months Hct/Hgb begins to rise within 2 wks, normalizing within 2 months Neurological function can improve within 24-48 hours, but complications can take months to years to resolve, and some may be irreversible
32
F &M : Vitamin B12 Deficiency Monitoring for Safety
Well tolerated, monitor inj site pain for IM and GI upset for PO Rare side effects: hyperuricemia and hypokalemia Elevated Vit B12 plasma levels associated with increased risk of cancer and mortality (causation not proven)